➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
McKinsey
Boehringer Ingelheim
Colorcon
AstraZeneca

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,974,826


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,974,826
Title:Methods comprising desmopressin
Abstract: The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.
Inventor(s): Klein; Bjarke Mimer (Frederiksberg, DK), Norgaard; Jens Peter (Frederiksberg, DK), Shumel; Brad (Chappaqua, NY)
Assignee: Ferring B.V. (Hoofddorp, NL)
Application Number:12/469,801
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,974,826
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 9,974,826

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 RX Yes No ⤷  Try it Free ⤷  Try it Free TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS ⤷  Try it Free
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-002 Jun 21, 2018 RX Yes Yes ⤷  Try it Free ⤷  Try it Free TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS, COMPRISING MONITORING A PATIENT'S SERUM SODIUM CONCENTRATION ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,974,826

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2724653 ⤷  Try it Free
Canada 2793502 ⤷  Try it Free
China 102821776 ⤷  Try it Free
China 106924716 ⤷  Try it Free
China 107252474 ⤷  Try it Free
China 110898207 ⤷  Try it Free
Denmark 2296686 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Mallinckrodt
Merck
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.